Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

PDL BioPharma, Inc.

Thumbshot of's website
http://www.pdl.com/

Protein Design Labs Incorporated, Freemont CA, United States of America.

PDL is a leader in the development of humanized monoclonal antibodies for the prevention and treatment of a variety of disease conditions. PDL currently has antibodies under development for autoimmune
Protein Design Labs Incorporated - Company Profile

Ticker -
PRW - Financial Information



PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million

Monday 8th of June 2009 8:30

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Google Custom Search
Browse other news from this organisation: PDL BioPharma, Inc.

Related Web-Links

(If any, Generated Automatically)
Google Custom Search

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2009

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.